Biomedical Sciences Advances 51 Graduate Students on the Path to Achieving Their PhDs
11/13/2024
On Thursday, November 7, the Biomedical Sciences Graduate Program (BIMS) proudly hosted its third annual Advancement to Candidacy Celebration. This event honors third-year BIMS students who have successfully passed their…
Younger Breast Cancer Diagnoses Increase as Survival Rates Improve
11/4/2024
A new report from the American Cancer Society released earlier this month reveals an increase in breast cancer diagnoses among women under 50. Researchers found breast cancer diagnosis rates increased year…
Ling Qi, PhD, Lab Discovers Mechanism Linking Cell Protein Degradation to Obesity and Diabetes
11/4/2024
Researchers from the Ling Qi Laboratory in the UVA Department of Molecular Physiology and Biological Physics have identified the SEL1L-HRD1 protein complex as a key player in regulating leptin receptor…
Research in Motion: Craig Portell, MD
11/4/2024
My work in clinical research in lymphoma is really focused on improving patient outcomes, so sometimes that means identifying groups of patients who may not have the best outcomes with…
Scientists Earn $7.4 Million for Lung Research Using Hyperpolarized Xenon MRI
11/4/2024
Three School of Medicine researchers, Jaime Mata, PhD, John P. Mugler, PhD, and Y. Michael Shim, MD, were awarded two, five-year NIH R01 grants totaling $7.4 million for research using…
Li Li, MD, PhD, Leads Research to Learn More About Colorectal Cancer
10/29/2024
Researchers at the University of Virginia are hard at work trying to understand one of the most pervasive forms of cancer: colorectal. While the overall rate of colon or rectal…
A Healthier Future—One Clinical Trial at a Time: An Interview With Mike McCulloch, MD
10/29/2024
Michael McCulloch, MD, has been part of the Division of Pediatric Cardiology at UVA Health Children’s Hospital since 2017. He serves as a professor of pediatrics and the medical director…
Research in Motion: Marilyn Huang, MD
10/29/2024
My primary research focus has been in developmental therapeutics and novel drug combinations across the spectrum of gynecologic malignancies, particularly with a focus in immunotherapy as a clinical trialist. —Marilyn…
